Accessible worldwide biomanufacturing is essential for promoting global health, ensuring equitable access to treatments, and strengthening health systems and economies. Genetic and regional differences require tailored vaccines and drugs to meet diverse population needs. Precision medicine, adapting manufacturing methods, and prioritizing diverse perspectives are crucial for achieving manufacturing sovereignty and improving healthcare outcomes. Initiatives like the African Vaccine Manufacturing Accelerator are addressing barriers to market entry. Small-footprint manufacturing, continuous methods like perfusion fermentation, and increased female representation are driving innovation in the industry. A human-centered approach combined with technological advancements can lead to a more equitable, flexible, and sustainable future for biomanufacturing.
Source link
Why Accessible, Worldwide Biomanufacturing Solutions are Paramount
